Structural characteristics and biological functions of human fibroblast growth factor receptor 4 Fc fusion protein

Fibroblast growth factors are a family of structurally related polypeptides that include at least eighteen members, widely involved in various physiological and pathological processes such as cell growth, differentiation, angiogenesis, tissue repair, and tumorigenesis.

Recent Advances
Product Information

Recent Advances

Structural Characteristics and Biological Functions of Human Fibroblast Growth Factor Receptor 4 Fc Fusion Protein

1. Overview of the Fibroblast Growth Factor Receptor Family

Fibroblast growth factors constitute a structurally related polypeptide family with at least eighteen members, extensively involved in numerous physiological and pathological processes such as cell growth, differentiation, angiogenesis, tissue repair, and tumorigenesis. These biological effects are mediated by a family of type I transmembrane tyrosine kinase receptors, known as fibroblast growth factor receptors. This receptor family comprises four highly homologous members encoded by four independent genes. Ligand binding induces receptor dimerization, triggering intracellular tyrosine residue autophosphorylation and subsequent activation of multiple downstream signaling cascades.

2. Molecular Structure and Tissue Distribution of FGFR4

FGFR4 is encoded by the FGFR4 gene and belongs to the receptor tyrosine kinase family. Its precursor protein undergoes processing to form a mature type I transmembrane glycoprotein with characteristic structure. The extracellular domain of FGFR4 contains an N-terminal signal peptide, three immunoglobulin-like domains, and an acid box region between IgI and IgII domains; the transmembrane region connects the extracellular domain with the intracellular split kinase domain possessing tyrosine kinase activity.

Unlike other FGFR family members, FGFR4 lacks the ability to generate multiple isoforms through alternative splicing, with only its α isoform identified to date. Additionally, alternative splicing in FGFR1 to FGFR3 involves the C-terminal half of the IgIII domain encoded by two mutually exclusive exons, producing receptor variants with alternative IgIII domains, whereas FGFR4 lacks this splicing diversity. FGFR4 is expressed in various tissues, and its expression pattern is closely related to ligand binding specificity, enabling it to perform unique functions in specific physiological and pathological processes.

3. Signaling Mechanisms and Biological Functions of FGFR4

As a high-affinity cell surface receptor for fibroblast growth factors, FGFR4 plays crucial roles in regulating cell proliferation, differentiation, migration, as well as lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism, and phosphate homeostasis. Upon ligand binding, FGFR4 undergoes homodimerization, activating its intracellular tyrosine kinase activity and leading to autophosphorylation. The phosphorylated receptor can phosphorylate downstream signaling molecules such as PLCG1 and FRS2. Activation of PLCG1 generates second messengers like diacylglycerol and inositol-1,4,5-trisphosphate, while phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1, and SOS1, subsequently activating the RAS-MAPK/ERK and AKT1 signaling pathways.

FGFR4 plays an irreplaceable role in bile acid metabolism regulation. In response to FGF19 stimulation, the FGFR4 signaling pathway negatively regulates the expression of CYP7A1 (the rate-limiting enzyme in bile acid synthesis), maintaining bile acid metabolic homeostasis. Additionally, FGFR4 promotes SRC-dependent phosphorylation of matrix metalloproteinase MMP14 and its lysosomal degradation, participating in extracellular matrix remodeling. FGFR4 signaling is downregulated through receptor endocytosis and degradation, with MMP14 facilitating the endocytosis and degradation of FGFR4.

Dysfunction of FGFR4 is closely associated with various diseases. Germline polymorphisms of the FGFR4 gene (e.g., the p.G388R variant) can enhance STAT3 signaling pathway activity, suppressing CD8 T cell expansion in regulatory T cells and participating in tumor immune microenvironment regulation. This variant is also linked to accelerated disease progression and poor prognosis in multiple cancers, including prostate, breast, colon, head and neck, lung, and skin cancers.

4. Molecular Design and Applications of FGFR4 Fc Fusion Protein

Fc fusion protein technology involves fusing the extracellular domain of a target protein with the Fc fragment of immunoglobulin G to enhance protein stability, prolong in vivo half-life, and facilitate purification via protein A affinity chromatography. Human FGFR4 Fc fusion protein typically consists of the extracellular region of FGFR4 (e.g., Met1-Asp369) fused with the Fc fragment of human IgG1. This recombinant protein is a disulfide-linked homodimer, with a theoretical monomer molecular weight of approximately 66 kDa under reducing conditions, but an apparent molecular weight of about 100-110 kDa on SDS-PAGE due to glycosylation modifications.

FGFR4 Fc fusion protein holds significant value in basic research and drug development. In ligand-receptor interaction studies, this fusion protein can serve as a "receptor trap" to competitively bind FGF ligands, inhibiting ligand-dependent cell proliferation. In CAR-T cell therapy research, FGFR4-Fc fusion protein is often used as a stimulatory antigen to evaluate CAR-T cell activation levels and cytokine release capacity. Furthermore, this protein can be employed in high-throughput screening of small molecule modulators and PROTAC degraders targeting the FGF signaling pathway, providing a crucial tool for targeted drug discovery.

5. Conclusion

As a key member of the fibroblast growth factor receptor family, FGFR4 performs unique biological functions in metabolic regulation, cell proliferation, and tumorigenesis. Its Fc fusion protein form serves as an important tool protein for studying FGFR4 signaling pathways, screening targeted drugs, and developing novel biological therapeutic strategies. Nanjing UniLove Biotechnology offers human FGFR4 recombinant protein products: FGFR4 Protein, catalog number UA080098, suitable for related basic research and drug development experiments.

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a high-tech enterprise with international competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：0571-87565022

more products

Product Information

The Last The Next